Stockreport

Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF US$0.22 loss per share (improved from US$0.25 loss in 1Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Cardiff Oncology Rev [Read more]